![]() Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases. | ![]() Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. | Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. | ||
Founding Date | Founding Date 1988 | Founding Date 1992 | Founding Date 2008 | Founding Date 1977 |
Type | Type Public | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations Leiden, NL HQ Leiden, NL | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations San Diego, US HQ | Locations Tourcoing, FR HQ Mouvaux, FR |
Employees | Employees 404 | Employees 10,6006% increase | Employees 43751% increase | Employees 901 |
Valuation ($) | Valuation ($) 590.3 m | Valuation ($) 40.3 b | Valuation ($) 5.1 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) $376.1m (FY, 2025) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) $7.7m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $41.6m (FY, 2025) | Cost of goods $553.5m (FY, 2020) | Cost of goods $1.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $341m (FY, 2025) | Gross profit $5.5b (FY, 2020) | Gross profit $6.6m (FY, 2025) | Gross profit N/A |
Net income | Net income $2.5m (FY, 2025) | Net income $603.4m (FY, 2020) | Net income ($465.3m) (FY, 2025) | Net income N/A |

Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.
View companyCrinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View companyMacopharma is a provider of blood transfusion and bio-sourced therapies.
View company